Weight loss also occurs at lower doses if higher doses are not tolerated due to side effects
It also reduces the risk of cardiovascular death, heart attack and stroke in patients who have overweight or obesity
Phenotyping is a way that clinicians segment the population, so you could segment a population on various characteristics: physical characteristics, behavioral characteristics, time lived with obesity, psychological characteristics
Alcohol consumption can affect glycemic control, and the combination of GLP-1 therapy with alcohol might increase hypoglycemia risk, particularly in patients taking concomitant insulin or sulfonylureas
Strategic Synergy: Optimizing Fat Loss With Combined Peptide Therapies Medical providers may recommend combining peptides, such as pairing a GLP-1 agonist with CJC-1295 or MOTS-c, to enhance fat loss, preserve muscle, and increase energy
Thats exactly why working with a dietitian helps